Phenotype—genotype relationships in monogenic disease: lessons from the thalassaemias

The remarkable phenotypic diversity of the β-thalassaemias reflects the heterogeneity of mutations at the β-globin locus, the action of many secondary and tertiary modifiers, and a wide range of environmental factors. It is likely that phenotype–genotype relationships will be equally complex in the case of many monogenic diseases. These findings highlight the problems that might be encountered in defining the relationship between the genome and the environment in multifactorial disorders, in which the degree of heritability might be relatively low and several environmental agents are involved. They also emphasize the value of an understanding of phenotype–genotype relationships in designing approaches to gene therapy.

[1]  Jennifer J. Pointon,et al.  Global prevalence of putative haemochromatosis mutations. , 1997, Journal of medical genetics.

[2]  R. Snow,et al.  A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya. , 1997, Human molecular genetics.

[3]  Y. C. Chang,et al.  Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2 , 1992 .

[4]  M. Alpers,et al.  alpha+-Thalassemia protects children against disease caused by other infections as well as malaria. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[5]  A. Oppenheim,et al.  Genetic analysis of β‐thalassemia intermedia in Israel: Diversity of mechanisms and unpredictability of phenotype , 1997, American journal of hematology.

[6]  D. Girelli,et al.  Haemochromatosis in patients with β‐thalassaemia trait , 2000, British journal of haematology.

[7]  A. Wilkie,et al.  Genetic heterogeneity in heterocellular hereditary persistence of fetal hemoglobin. , 1997, Blood.

[8]  T. Huisman,et al.  DNA sequence variation associated with elevated fetal G gamma globin production. , 1985, Blood.

[9]  M. Romano,et al.  Clinical features of thalassemia intermedia in Italy. , 1987, Birth defects original article series.

[10]  D. Weatherall,et al.  Association of thalassaemia intermedia with a beta‐globin gene haplotype , 1987, British journal of haematology.

[11]  N. Olivieri,et al.  Hemoglobin E/β Thalassemia: The Canadian Experience , 1998 .

[12]  C. Newbold,et al.  High incidence of malaria in α-thalassaemic children , 1996, Nature.

[13]  S. Deutsch,et al.  Severe inclusion body β‐thalassaemia with haemolysis in a patient double heterozygous for β°‐thalassaemia and quadruplicated α‐globin gene arrangement of the anti‐4.2 type , 1999 .

[14]  J. Clegg,et al.  THE CLINICAL AND MOLECULAR HETEROGENEITY OF THE THALASSEMIA SYNDROMES * , 1980, Annals of the New York Academy of Sciences.

[15]  M. Idelson,et al.  Bone mineral metabolism in adults with β‐thalassaemia major and intermedia , 2000 .

[16]  J. B. Clegg,et al.  The thalassaemia syndromes , 1965 .

[17]  W. Wanachiwanawin,et al.  Effect of pyrexia in the formation of intraerythrocytic inclusion bodies and vacuoles in haemolytic crisis of haemoglobin H disease , 1994, European journal of haematology.

[18]  G. Lathrop,et al.  Dissecting the loci controlling fetal haemoglobin production on chromosomes 11p and 6q by the regressive approach , 1996, Nature Genetics.

[19]  E. Schwartz The silent carrier of beta thalassemia. , 1969, The New England journal of medicine.

[20]  N. Andrews,et al.  Iron homeostasis: insights from genetics and animal models , 2000, Nature Reviews Genetics.

[21]  S. Perrotta,et al.  Osteoporosis in β‐thalassaemia major patients: analysis of the genetic background , 2000, British journal of haematology.

[22]  D. Weatherall Pathophysiology of thalassaemia. , 1998, Bailliere's clinical haematology.

[23]  J. Clegg,et al.  A novel α-globin gene arrangement in man , 1980, Nature.

[24]  D. Kwiatkowski,et al.  Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria , 1994, Nature.

[25]  A. Cao,et al.  Hyperbilirubinaemia in heterozygous β‐thalassaemia is related to co‐inherited Gilbert's syndrome , 1997, British journal of haematology.

[26]  G. Stamatoyannopoulos,et al.  The molecular basis of blood diseases , 1987 .

[27]  S. Thein,et al.  Nontransfusional Iron Overload in Thalassemia: Association with Hereditary Hemochromatosis , 1998, Annals of the New York Academy of Sciences.

[28]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[29]  N. Olivieri,et al.  Thalassaemia in Sri Lanka: implications for the future health burden of Asian populations , 2000, The Lancet.

[30]  R. Galanello,et al.  Molecular analysis of beta zero-thalassemia intermedia in Sardinia. , 1989, Blood.

[31]  E. Kanavakis,et al.  The triplicated alpha gene locus and beta thalassaemia. , 1983, British journal of haematology.

[32]  D. Weatherall Thalassemia in the Next Millennium: Keynote Address a , 1998, Annals of the New York Academy of Sciences.

[33]  G. Stamatoyannopoulos,et al.  Inclusion-Body β-Thalassemia Trait , 1974 .

[34]  Andrew J. McMichael,et al.  Common West African HLA antigens are associated with protection from severe malaria , 1991, Nature.

[35]  K. Summers Relationship between genotype and phenotype in monogenic diseases: Relevance to polygenic diseases , 1996, Human mutation.

[36]  D. Weatherall Gene therapy: Repairing haemoglobin disorders with ribozymes , 1998, Current Biology.

[37]  S. Thein IS IT DOMINANTLY INHERITED β THALASSAEMIA OR JUST A β‐CHAIN VARIANT THAT IS HIGHLY UNSTABLE? , 1999 .

[38]  A. Kutlar,et al.  A C----T substitution at nt--101 in a conserved DNA sequence of the promotor region of the beta-globin gene is associated with "silent" beta-thalassemia. , 1989, Blood.

[39]  J. Clegg,et al.  MOLECULAR BASIS FOR MILD FORMS OF HOMOZYGOUS BETA-THALASSAEMIA , 1981, The Lancet.

[40]  T. Huisman,et al.  Possible factors influencing the haemoglobin and fetal haemoglobin levels in patients with β‐thalassaemia due to a homozygosity for the IVS‐I‐6 (T→C) mutation , 1994, British journal of haematology.

[41]  A. Kutlar,et al.  Clinical and genetic heterogeneity in black patients with homozygous beta-thalassemia from the southeastern United States. , 1988, Blood.

[42]  P. Grisanti,et al.  Silent thalassemias: genotypes and phenotypes. , 1997, Haematologica.

[43]  M Farrall,et al.  Genetic influences on F cells and other hematologic variables: a twin heritability study. , 2000, Blood.

[44]  Y. Kan,et al.  Mild thalassemia: the result of interactions of alpha and beta thalassemia genes. , 1970, The Journal of clinical investigation.

[45]  J. Clegg,et al.  Why are hemoglobin F levels increased in HbE/beta thalassemia? , 1999, Blood.

[46]  D. J. Weatherall,et al.  4 Pathophysiology of thalassaemia , 1998 .

[47]  Wonke BONE DISEASE IN β‐THALASSAEMIA MAJOR , 1998 .

[48]  J. Clegg,et al.  A Genetically Determined Disorder with Features both of Thalassaemia and Congenital Dyserythropoietic Anaemia , 1973, British journal of haematology.

[49]  A. Dawson Bailliere's Clinical Haematology - International Practice and Research , 1988 .

[50]  D. Weatherall,et al.  Thalassaemia intermedia. , 1987, Blood reviews.

[51]  W. Wood,et al.  The triplicated α gene locus and β thalassaemia , 1983 .

[52]  J. Clegg,et al.  The Clinical and Biosynthetic Characterization of αβ‐Thalassaemia , 1972, British journal of haematology.

[53]  H. Bunn Pathogenesis and treatment of sickle cell disease. , 1997, The New England journal of medicine.

[54]  A. Sachs,et al.  Messenger RNA degradation in eukaryotes , 1993, Cell.

[55]  ScienceDirect Baillière's clinical haematology , 1998 .

[56]  M. Hentze,et al.  Binary specification of nonsense codons by splicing and cytoplasmic translation , 1998, The EMBO journal.

[57]  M. Cappellini,et al.  The expression of uridine diphosphate glucuronosyltransferase gene is a major determinant of bilirubin level in heterozygous β‐thalassaemia and in glucose‐6‐phosphate dehydrogenase deficiency , 1997, British journal of haematology.

[58]  J. Clegg,et al.  Molecular basis for dominantly inherited inclusion body beta-thalassemia. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[59]  Hall,et al.  Beta‐thalassaemia intermedia: is it possible consistently to predict phenotype from genotype? , 1998, British journal of haematology.

[60]  M. Russell,et al.  Blood and urinary nicotine in non-smokers , 1975, The Lancet.

[61]  S. Thein,et al.  Erythroblastic Inclusions in Dominantly Inherited β Thalassemias , 1997 .

[62]  J. Clegg,et al.  Thalassemia — a global public health problem , 1996, Nature Medicine.

[63]  C. Thompson,et al.  The interaction of anti 3.7 type quadruplicated alpha-globin genes and heterozygous beta-thalassemia. , 1989, Hemoglobin.

[64]  D. Labie,et al.  Common haplotype dependency of high G gamma-globin gene expression and high Hb F levels in beta-thalassemia and sickle cell anemia patients. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[65]  D. Weatherall,et al.  The role of genomics in studying genetic susceptibility to infectious disease. , 1997, Genome research.

[66]  D. Weatherall,et al.  Genetic influences on bone disease in thalassemia. , 1998 .

[67]  G. Sciarratta,et al.  The Silent Carrier of β‐Thalassemia , 1985 .

[68]  Stylianos E. Antonarakis,et al.  Abnormal RNA processing due to the exon mutation of βE-globin gene , 1982, Nature.

[69]  S. Boyer,et al.  Fetal hemoglobin restriction to a few erythrocytes (F cells) in normal human adults. , 1975, Science.

[70]  U. Wolf Identical mutations and phenotypic variation , 1997, Human Genetics.

[71]  W. Wood,et al.  β + Thalassaemia—Portuguese type: clinical, haematological and molecular studies of a newly defined form of β thalassaemia , 1983 .

[72]  G. Stamatoyannopoulos,et al.  Triplicated alpha-globin loci in humans. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[73]  J. Clegg,et al.  The Hemoglobin E Syndromes , 1998, Annals of the New York Academy of Sciences.

[74]  S. Perrotta,et al.  Osteoporosis in beta-thalassaemia major patients: analysis of the genetic background. , 2000 .

[75]  L. Maquat,et al.  Intron function in the nonsense-mediated decay of beta-globin mRNA: indications that pre-mRNA splicing in the nucleus can influence mRNA translation in the cytoplasm. , 1998, RNA.

[76]  D. Weatherall,et al.  From genotype to phenotype: genetics and medical practice in the new millennium. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[77]  J. Clegg,et al.  Is hemoglobin instability important in the interaction between hemoglobin E and beta thalassemia? , 1998, Blood.

[78]  S. Thein DOMINANT β THALASSAEMIA: MOLECULAR BASIS AND PATHOPHYSIOLOGY , 1992 .

[79]  E. Rachmilewitz,et al.  Beta O-thalassemia intermedia , 1978 .